Late stage trials in Brazil for China's Sinovac Biotech COVID-19 vaccine have shown promising results, positioning it for public use, the Wall Street Journal reported Monday. The vaccine, CoronaVac, has reached Phase 3 trials in Brazil, the first country to ...
from Google Alert - health https://ift.tt/3aB5Zaq
via IFTTT
0 comments:
Post a Comment